Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DMT210 Gel in moderate to severe acne rosacea
NCT03003104Phase 2Completed
- Sponsor
- Dermata Therapeutics
- Start
- Jan 2017
- Primary completion
- Aug 2017
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of DMT210 in rosacea, sponsored by Dermata Therapeutics. Started Jan 2017; status: completed.
02
Drugs
DMT210
03
Conditions
rosacea
Beyond the preview
Go deeper on NCT03003104.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03003104.